Multiple Sclerosis News

The June meeting of Keep S'myelin will be held Thursday, June 6, 11:30 a.m. at Kno-Wal-Lin Home Care and Hospice at 170 Pleasant St.

Kari Antin, a 40-year-old financial analyst in Minneapolis, knows she's taking a life-or-death risk with every monthly infusion of Biogen Idec Inc.'s Tysabri.

Walk More than 100 people came together at Edwards Park for this year's Walk MS: Charleston on May 4. The Greater Carolinas Chapter of the National Multiple Sclerosis Society is excited to announce more than 100 people came together at Edwards Park for this year's Walk MS: Charleston on May 4. Walk MS, presented by Biogen Idec, is an opportunity ... (more)

SWINDON Therapy Centre is encouraging people to take part in the MS Challenge 2013 to help raise money for the centre.

Specialty drugmaker Biogen Idec said Tuesday it submitted a new injectable multiple sclerosis drug to the Food and Drug Administration for U.S. market approval.

By Dale Bass - Kamloops This Week Published: May 22, 2013 4:00 PM Updated: May 22, 2013 4:34 PM Kamloopsians being treated for multiple sclerosis will no longer have to leave the Tournament Capital as an outreach clinic will be opening in the city next month.

The centre management team will be fund-raising on Friday, May 31, as part of the MS Society's Cake Break event.

Beaver Creek Resort Co. has selected Can Do MS as the beneficiary of its second annual Cut and Slice Golf Event presented by US Bank, to be held on Monday at the Beaver Creek Golf Club from 11:30 a.m. to 4 p.m. Golfers also will enjoy barbecue and craft beers from Crazy Mountain Brewery and Breckenridge Brewery around the course.

A new Commonwealth grant for researching multiple sclerosis is expected to advance existing research collaborations and enable new ones.

Express Scripts expects spending on specialty medications in the U.S. to jump 67 percent by the end of 2015, according to a new company study released Tuesday.

In this video, health-care analyst David Williamson discusses Biogen's latest drug up for FDA approval.

The aetiology of multiple sclerosis remains unknown. This hampers molecular diagnosis and the discovery of bio-molecular markers.

A biologics license application has been submitted to the FDA for approval of Plegridy , a pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis .

Plegridya is Biogen Idec's newly developed subcutaneously administered multiple sclerosis drug therapy and it as just been announced today that it has been submitted to the FDA for the okay to put on the market.

Main Category: Diabetes Also Included In: Immune System / Vaccines ; Multiple Sclerosis ; Arthritis / Rheumatology Article Date: 21 May 2013 - 1:00 PDT Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been ... (more)

A pivotal phase III study of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis was unsuccessful in demonstrating that the drug provided statistically significant improvement compared with placebo in the trial's co-primary endpoints.

Multiple sclerosis , a neurological disease that affects millions of people all across the world, harms everyone who has this disease is such unbelievable ways and, as of yet, finding a cure has proved incredibly allusive.

XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition significantly compared with a placebo.

In this video, health-care analyst David Williamson discusses why Biogen Idec 's party may just be getting started despite a huge run in the stock already.

'Only cannabis spray relieves my MS - so why won't the NHS give it to me?' Sufferer refused drug to help ease affects of disease Mr Rudd was refused Sativex on the NHS while sufferers living a few miles away are being prescribed the cannabis spray The drug hasn't been assessed by the National Institute for Health and Clinical Excellence - meaning ... (more)